[go: up one dir, main page]

EE200000154A - Nikotiini sisaldav kompositsioon ja selle valmistamismeetod - Google Patents

Nikotiini sisaldav kompositsioon ja selle valmistamismeetod

Info

Publication number
EE200000154A
EE200000154A EEP200000154A EEP200000154A EE200000154A EE 200000154 A EE200000154 A EE 200000154A EE P200000154 A EEP200000154 A EE P200000154A EE P200000154 A EEP200000154 A EE P200000154A EE 200000154 A EE200000154 A EE 200000154A
Authority
EE
Estonia
Prior art keywords
offspring
precursors
liquid crystals
dispersions
nicotine
Prior art date
Application number
EEP200000154A
Other languages
English (en)
Estonian (et)
Inventor
B�rje Andersson Sven
Jonn Stefan
Landh Tomas
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of EE200000154A publication Critical patent/EE200000154A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Dispersion Chemistry (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EEP200000154A 1997-09-25 1998-09-15 Nikotiini sisaldav kompositsioon ja selle valmistamismeetod EE200000154A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9703458A SE9703458D0 (sv) 1997-09-25 1997-09-25 Nicotine compositions and methods of formulation thereof
PCT/SE1998/001632 WO1999015171A1 (en) 1997-09-25 1998-09-15 Nicotine compositions and methods of formulation thereof

Publications (1)

Publication Number Publication Date
EE200000154A true EE200000154A (et) 2001-02-15

Family

ID=20408364

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000154A EE200000154A (et) 1997-09-25 1998-09-15 Nikotiini sisaldav kompositsioon ja selle valmistamismeetod

Country Status (22)

Country Link
EP (1) EP1023069B1 (fi)
JP (1) JP2001517624A (fi)
KR (1) KR20010024305A (fi)
CN (1) CN1123343C (fi)
AT (1) ATE253362T1 (fi)
AU (1) AU733619B2 (fi)
BR (1) BR9815395A (fi)
CA (1) CA2304042A1 (fi)
DE (1) DE69819548T2 (fi)
DK (1) DK1023069T3 (fi)
EE (1) EE200000154A (fi)
ES (1) ES2210817T3 (fi)
FI (1) FI20000692L (fi)
HU (1) HUP0004802A3 (fi)
MX (1) MXPA00002955A (fi)
NO (1) NO20001540L (fi)
NZ (1) NZ503408A (fi)
PT (1) PT1023069E (fi)
RU (1) RU2201747C2 (fi)
SE (1) SE9703458D0 (fi)
WO (1) WO1999015171A1 (fi)
ZA (1) ZA988794B (fi)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638621B2 (en) 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
US6799576B2 (en) 1999-07-16 2004-10-05 Aradigm Corporation System for effecting smoking cessation
US8256433B2 (en) 1999-07-16 2012-09-04 Aradigm Corporation Systems and methods for effecting cessation of tobacco use
AT409219B (de) * 1999-08-13 2002-06-25 Red Bull Gmbh Verwendung von nikotin zum herstellen von arzneimitteln
KR100381622B1 (ko) * 2000-08-30 2003-04-26 디디에스텍주식회사 자극성을 줄인 염기성 약물의 구강 투여 조성물
DE10057769A1 (de) * 2000-11-22 2002-05-23 Beiersdorf Ag Haarpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
SE521512C2 (sv) 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
AU2003209750A1 (en) * 2002-03-30 2003-10-13 Gunther Beisel Preparation containing fatty acid, used for reducing appetite, satiating, and/or reducing weight
US20040002520A1 (en) * 2002-07-01 2004-01-01 Soderlund Patrick L. Composition and method for cessation of Nicotine cravings
KR100443722B1 (ko) * 2002-09-26 2004-08-09 이용원 니코틴을 함유한 하드츄잉캔디 및 그의 제조방법
FI3473251T3 (fi) 2002-12-20 2024-01-09 Niconovum Ab Nikotiini-selluloosa-kombinaatio
FR2851470B1 (fr) * 2003-02-20 2007-11-16 Besins Int Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse
US10172810B2 (en) 2003-02-24 2019-01-08 Pharmaceutical Productions, Inc. Transmucosal ketamine delivery composition
US9254294B2 (en) 2003-02-24 2016-02-09 Pharmaceutical Productions Inc. Transmucosal hormone delivery system
US9498454B2 (en) * 2003-02-24 2016-11-22 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US9358296B2 (en) 2003-02-24 2016-06-07 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US8992974B2 (en) 2003-02-24 2015-03-31 Pharmaceuticals Productions, Inc. Transmucosal drug delivery system
RU2250052C2 (ru) * 2003-05-16 2005-04-20 Квасенков Олег Иванович Способ производства некурительного табачного изделия
RU2250057C2 (ru) * 2003-05-16 2005-04-20 Квасенков Олег Иванович Способ производства некурительного табачного изделия
RU2250051C2 (ru) * 2003-05-16 2005-04-20 Квасенков Олег Иванович Способ производства некурительного табачного изделия
AU2004259006B2 (en) * 2003-07-24 2010-10-07 Glaxosmithkline Llc Orally dissolving films
GB0322033D0 (en) * 2003-09-19 2003-10-22 Camurus Ab Composition
BRPI0415741B1 (pt) 2003-11-07 2013-07-23 composições de tabaco e métodos de fabricação de uma composição de tabaco
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US7125954B2 (en) 2005-01-27 2006-10-24 General Electric Company Method for producing polyether polymers
US20080219935A1 (en) * 2005-07-08 2008-09-11 Sang-Hoon Kwak Phase Transitive Breath Care Products
AU2007224584A1 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
WO2007118653A2 (de) * 2006-04-11 2007-10-25 Koko Kosmetikvertrieb Gmbh & Co. Kg Nanopartikel, enthaltend nicotin und/oder cotinin, dispersionen und die verwendung derselben
US20080287507A1 (en) * 2007-05-16 2008-11-20 John Hedenstrom Nicotine containing toiletry waters
GB2469792A (en) * 2009-04-23 2010-11-03 Calvin John Ross Oil-based pharmaceutical formulation for sublingual delivery
GB2476471A (en) * 2009-12-22 2011-06-29 Norwich Pharma Technologies Ltd Cotinine formulation for the treatment of obesity
US8846725B2 (en) * 2011-01-24 2014-09-30 Quadex Pharmaceuticals, Llc Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
CN102552405B (zh) * 2012-03-21 2013-10-16 张伟 一种肛周术后麻醉镇痛的药物组合物的制备方法
CN103040741B (zh) * 2012-12-11 2014-11-05 中山大学 溶致液晶的前体混悬液及其制备方法
EP2964190A1 (en) * 2013-03-07 2016-01-13 Danmarks Tekniske Universitet Nano-microdelivery systems for oromucosal delivery of an active ingredient
HUE069174T2 (hu) * 2013-05-06 2025-02-28 Juul Labs Inc Nikotinsó készítmények aeroszolos eszközökhöz és ezek eljárásai
WO2015090337A1 (en) * 2013-12-20 2015-06-25 Fertin Pharma A/S Nicotine powder composition
KR20190075168A (ko) * 2014-04-08 2019-06-28 필립모리스 프로덕츠 에스.에이. 니코틴 제형 및 이의 제조방법
GB201414919D0 (en) * 2014-08-21 2014-10-08 Corbitt Terence Simon Formulations for transmucosal delivery
JP6882303B2 (ja) * 2016-01-13 2021-06-02 エルジー ハウスホールド アンド ヘルスケア リミテッド 口腔用製剤
CN108323791B (zh) * 2018-01-03 2021-02-12 云南中烟工业有限责任公司 一种尼古丁-氧化锌复合物、其制备方法及包含其的烟草制品
MX2020010908A (es) * 2018-04-16 2021-03-25 Poviva Corp Composiciones infundidas con compuestos de nicotina y metodos de uso de las mismas.
CN109125251B (zh) * 2018-09-10 2021-08-13 武汉百纳礼康生物制药有限公司 一种包载蛋白类药物的温敏性液晶凝胶制剂及其制备方法
KR102186704B1 (ko) * 2019-02-18 2020-12-04 (주)아이엠디팜 서방성 지질 전구 제제 및 이를 포함하는 지질 용액 형태의 서방성 주사용 약학 조성물
LU101511B1 (en) * 2019-12-02 2021-06-04 Herrera Arturo Solis (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a parenteral administration and a process for the preparation of an injectable substance
LU101520B1 (en) * 2019-12-02 2021-06-07 Herrera Arturo Solis (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a homogeneous, viscous, semi-solid topical medication and topical medication
US12137723B2 (en) 2019-12-09 2024-11-12 Nicoventures Trading Limited Oral products with active ingredient combinations
NL2031331B1 (en) 2022-03-18 2023-09-29 Plethora Therapeutics B V Transmucosal delivery of a short-acting psychedelic compound
NL2031332B1 (en) 2022-03-18 2023-09-29 Plethora Therapeutics B V Transmucosal delivery of psychoactive compounds
EP4570082A1 (en) * 2023-12-15 2025-06-18 Contraf-Nicotex-Tobacco GmbH Oral product for delivery of nicotine comprising a nicotine salt of a fatty acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5371109A (en) * 1986-07-01 1994-12-06 Drilletten Ab Controlled release composition for a biologically active material dissolved or dispersed in an L2-phase
IL86170A (en) * 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
US4908213A (en) * 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine
GB2230439A (en) * 1989-04-20 1990-10-24 Alec Stanley Walter Shaw Nicotine lozenges
AU2699892A (en) * 1991-10-04 1993-05-03 Gs Biochem Ab Particles, method of preparing said particles and uses thereof
JPH11513393A (ja) * 1995-10-12 1999-11-16 ジーエス ディベロップメント エービー 皮膚又は粘膜表面へのもしくは介する活性物質の投与用医薬組成物

Also Published As

Publication number Publication date
DE69819548D1 (de) 2003-12-11
KR20010024305A (ko) 2001-03-26
HUP0004802A2 (hu) 2001-05-28
FI20000692A7 (fi) 2000-03-24
CA2304042A1 (en) 1999-04-01
EP1023069B1 (en) 2003-11-05
HUP0004802A3 (en) 2001-12-28
NZ503408A (en) 2004-12-24
WO1999015171A1 (en) 1999-04-01
PT1023069E (pt) 2004-02-27
SE9703458D0 (sv) 1997-09-25
DE69819548T2 (de) 2004-08-12
AU733619B2 (en) 2001-05-17
JP2001517624A (ja) 2001-10-09
EP1023069A1 (en) 2000-08-02
DK1023069T3 (da) 2004-03-08
RU2201747C2 (ru) 2003-04-10
ES2210817T3 (es) 2004-07-01
CN1123343C (zh) 2003-10-08
BR9815395A (pt) 2000-11-14
NO20001540D0 (no) 2000-03-24
ZA988794B (en) 1999-04-01
FI20000692L (fi) 2000-03-24
MXPA00002955A (es) 2002-04-24
ATE253362T1 (de) 2003-11-15
NO20001540L (no) 2000-05-25
CN1278174A (zh) 2000-12-27
AU9287298A (en) 1999-04-12

Similar Documents

Publication Publication Date Title
EE200000154A (et) Nikotiini sisaldav kompositsioon ja selle valmistamismeetod
EP1768625A4 (en) COMPOSITIONS OF DELAYED RELEASE WITH PROGESTERONE RECEPTOR MODULATORS
BR0214806A (pt) Composições farmacêuticos de 5,7,14-triazatetraciclo-{10.3.1.02,11.0,4,9]-hexadeca-2(1 1),3,5,7,9-penteno
EP1124551A4 (en) AEROSOL-DOSERS FOR DELTA 9 -TETRAHYDROCANNABINOL SOLUTION (DELTA 9 THC) AND THEIR METHOD OF USE
RU94040387A (ru) Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака
BR0110767A (pt) Derivados de piperidina farmaceuticamente ativos, em particular como moduladores da atividade de receptor de quimiocina
DE60202477D1 (de) Vorrichtung zur verabreichung einer substanz
HRP20050781B1 (hr) Metode i farmaceutske mješavine za pouzdano postizanje prihvatljivih razina testosterona u serumu
EA200900451A1 (ru) Способ получения композиции эстрадиола с медленным высвобождением ( варианты ), микросферы эстрадиола и холестерина и способ для одновременной контрацепции и гормонозамещения
AU2284001A (en) Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
NO20055766L (no) Positive modulatorer av nikotinacetylcholinreseptorer
ITRM920900A1 (it) Formulazione proteica coadiuvante nella prevenzione e cura delle parodontiti e di altre patologie batteriche del cavo orale.
EP1344526A4 (en) PROPHYLACTIC / THERAPEUTIC AGENTS FOR INFLAMMATORY RESPIRATORY DISEASES
WO2004024187A3 (en) Compositions to reduce congestion and methods for application thereof to the nasal membrane
BRPI0411702B8 (pt) uso de ácido hialurônico para preparar composições para o tratamento de aftas da cavidade oral
ATE220912T1 (de) Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung
AU1549700A (en) Ion channel modulating agents
UY25510A1 (es) Procedimiento para la producción de preparados efervescentes
DE59914183D1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
AU4537500A (en) Ion channel modulating agents
PT1198224E (pt) Formulacoes de solucoes de esteroides para administracao por inalacao
BRPI0417530B8 (pt) composição para a liberação transdérmica de hormônios sem a necessidade de melhoradores de penetração, sistema terapêutico transdérmico, e kit
ATE241974T1 (de) Nimelulide enthaltendes pharmazeutisches präparat zur oralen verabreichung
MX4362E (es) Procedimiento para la preparacion de una composicion dental mejorada
MIYAZAWA et al. Clinical study of postoperative maxillary cyst